Á¦³×¸¯ ÀǾàǰ ½ÃÀåÁ¶»çº¸°í¼­

Global InformationÀÌ Á¦°øÇϰí ÀÖ´Â Á¦³×¸¯ ÀǾàǰ(Generics), ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar), ¹ÙÀÌ¿Àº£ÅÍ(Biobetter) °ü·Ã º¸°í¼­¿¡¼­´Â ÇöÀç¿Í ÇâÈÄÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ȯ°æ ºÐ¼® Á¤º¸¸¦ ÀüÇØµå¸®°í ÀÖ½À´Ï´Ù. ¶Ç ƯÇã ¸¸·á ´ëÃ¥°ú ÀǾàǰ ¼ö¸íÁֱ⠰ü¸®, ½ÃÀå ÁøÃâ ±âȸ, ½ÇÀû »óÈ£ºñ±³ µîÀÇ Á¤º¸µµ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 131°Ç)
¼¼°èÀÇ Àν¶¸° °¨ÀÛÁ¦ ½ÃÀå
Insulin Sensitizers
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,496,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦³×¸¯ ÀÛ¹° º¸È£ È­ÇÐÁ¦Ç° ½ÃÀå : ¿¹Ãø - À¯Çüº°, ÀÛ¹° À¯Çüº°, Á¦Á¦º°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(-2032³â)
Generic Crop Protection Chemicals Market Forecasts to 2032 - Global Analysis By Type (Herbicides, Insecticides, Fungicides and Other Types), Crop Type, Formulation, Application and By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,150 £Ü 6,027,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå
Biosimilar Monoclonal Antibody
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,496,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼®(Á¾·ùº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°) ¹× ¿¹Ãø(2022-2032³â)
Global Biosimilar Monoclonal Antibodies Market Size study, by Type, by Indication, by End User, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 7,189,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç° Ŭ·¡½ºº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2018-2032³â)
United States Biosimilars Market Assessment, By Product Class, By Indication By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,500 £Ü 5,083,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÁÖ»ç Àν¶¸° ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030³â)
Non-Injectable Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Çüº°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°, ¿¹Ãø(2022-2032³â)
Global Inhalation And Nasal Spray Generic Drugs Market Size study, by Dosage Form, by Therapeutic Area, by End User, by Distribution Channel, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 7,189,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå º¸°í¼­(2025³â)
Short-Acting Insulin Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
ºê·£µå Á¦³×¸¯ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, ¿ëµµ, Åõ¿© °æ·Î, À¯Åë ä³Î, Áö¿ª(2026-2032³â)
Branded Generics Market By Drug Class, Application, Route of Administration, Distribution Channel, & Region for 2026-2032
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,950 £Ü 5,736,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Biosimilar Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2018-2032³â)
Insulin Market Assessment, By Product, By Type, By Application, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,800 £Ü 6,971,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : Á¦Ç° À¯Çü, ¾àÁ¦ Ŭ·¡½ºº°, Åõ¿© °æ·Î, ȯÀÚ À¯Çü, Ä¡·á ¿ëµµ, À¯Åë ä³Î - ¿¹Ãø(2025-2030³â)
Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,721,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ÀÇ»çÀÇ ·»Á ÅëÇÑ Àü¸Á
Biosimilars - Through the Physician's Lens
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 1,950 £Ü 2,832,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºê·£µå Á¦³×¸¯ ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾àÁ¦ Ŭ·¡½ºº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Branded Generics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Class, By Application, By Distribution Channel, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
±âÀú Àν¶¸° ½ÃÀå : À¯Çüº°, Åõ¿© µð¹ÙÀ̽ºº°, ÀûÀÀÁõº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, Áö¿ªº°
Basal Insulin Market, By Type, By Delivery Device, By Indication, By Age Group, By Distribution Channel, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° °¨ÀÛÁ¦ ½ÃÀå : Àν¶¸° °¨ÀÛÁ¦ À¯Çüº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°
Insulin Sensitizers Market, By Type of Insulin Sensitizers, By Indication, By Route of Administration, By Distribution Channel, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È޹̶ó ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, ȯÀÚ ¿¬·Éº°, Áö¿ªº°
Humira Biosimilar Market, By Product Type, By Indication, By Distribution Channel, By Patient Age, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ¹Ì±¹ ÁöºÒÀÚÀÇ °üÁ¡
Biosimilars: US Payers' Perspective
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 8,000 £Ü 11,619,000 (ºÎ°¡¼¼ º°µµ)
Ư¼ö Á¦³×¸¯ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Åõ¿© °æ·Îº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀï ½ÃÀ庰(2020-2030³â)
Specialty Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration, By Indication, By Distribution Channel, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
Àν¶¸° ±Û¶óÁø : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ, Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)
Insulin Glargine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,750 £Ü 6,898,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå
Biosimilars: Global Markets
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,650 £Ü 6,753,000 (ºÎ°¡¼¼ º°µµ)
G-CSF(°ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ) ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
G-CSF (Granulocyte Colony Stimulating Factor) Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 3,850 £Ü 5,591,000 (ºÎ°¡¼¼ º°µµ)
Á¦³×¸¯ ÀǾàǰ À§Å¹ Á¦Á¶ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ÀǾàǰ À¯Çüº°, Á¦Ç° À¯Çüº°, Åõ¿© °æ·Îº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø, (2025-2030³â)
Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 5,950 £Ü 8,641,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå(2025-2029³â)
Global Generic Drugs Market 2025-2029
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 2,500 £Ü 3,631,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÁÖ»ç Àν¶¸° ½ÃÀå(2025³â)
Non-injectable Insulin Global Market Report 2025
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,490 £Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.